- Home
- PDSB vs DXR Comparison
PDSB vs DXR Comparison
Compare PDSB & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- DXR
- Stock Information
- Founded
- PDSB 2005
- DXR 1970
- Country
- PDSB United States
- DXR United States
- Employees
- PDSB N/A
- DXR N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- DXR Medical/Dental Instruments
- Sector
- PDSB Health Care
- DXR Health Care
- Exchange
- PDSB Nasdaq
- DXR Nasdaq
- Market Cap
- PDSB 43.1M
- DXR 36.4M
- IPO Year
- PDSB N/A
- DXR N/A
- Fundamental
- Price
- PDSB $1.58
- DXR $7.74
- Analyst Decision
- PDSB Strong Buy
- DXR Strong Buy
- Analyst Count
- PDSB 2
- DXR 1
- Target Price
- PDSB $10.00
- DXR $25.00
- AVG Volume (30 Days)
- PDSB 636.9K
- DXR 4.1K
- Earning Date
- PDSB 05-14-2025
- DXR 01-01-0001
- Dividend Yield
- PDSB N/A
- DXR N/A
- EPS Growth
- PDSB N/A
- DXR 86.16
- EPS
- PDSB N/A
- DXR 0.11
- Revenue
- PDSB N/A
- DXR $119,714.00
- Revenue This Year
- PDSB N/A
- DXR N/A
- Revenue Next Year
- PDSB N/A
- DXR N/A
- P/E Ratio
- PDSB N/A
- DXR $71.21
- Revenue Growth
- PDSB N/A
- DXR N/A
- 52 Week Low
- PDSB $0.85
- DXR $6.55
- 52 Week High
- PDSB $4.42
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- PDSB 66.13
- DXR 52.10
- Support Level
- PDSB $1.24
- DXR $7.40
- Resistance Level
- PDSB $1.66
- DXR $8.13
- Average True Range (ATR)
- PDSB 0.11
- DXR 0.36
- MACD
- PDSB 0.03
- DXR 0.05
- Stochastic Oscillator
- PDSB 69.42
- DXR 62.14
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.